RELMADA THERAPEUTICS, INC.

A clinical-stage biotech developing novel therapies for CNS diseases and oncology.

RLMD | NDAQ

Overview

Corporate Details

ISIN(s):: US75954H1005 (+1 more)
LEI:
Country:: United States of America
Address:: 2222 PONCE DE LEON BLVD. 3RD FLOOR, 33134 CORAL GABLES
Website:: https://www.relmada.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative and novel treatments for debilitating disorders. The company's primary research area is central nervous system (CNS) diseases, with a significant focus on therapies for major depressive disorder (MDD), including its lead candidate esmethadone. Relmada is also advancing its development pipeline into oncology, with programs such as NDV-01 for urologic cancers. The company's mission is to create transformative medicines that improve human health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
	2025-11-04 13:00	Regulatory News Service 8-K - RELMADA THERAPEUTICS, INC. (0001553643) (Filer)	English	34.7 MB

Automate Your Workflow. Get a real-time feed of all RELMADA THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RELMADA THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for RELMADA THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Psomagen, Inc. A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.	United States of America	950200
Public Policy Holding Company, Inc. Advisory group providing public policy, government relations, and strategic communications services.	United States of America	PPHC.L
Purple Biotech Ltd. Developing cancer therapies to overcome tumor immune evasion and drug resistance.	Israel	PPBT
Qualigen Therapeutics, Inc. A clinical-stage company developing innovative treatments for rare cancers in adults and children.	United States of America	QLGN
QUIA PHARMA AB Develops biobetters by enhancing approved drugs with a patented drug delivery platform.	Sweden	QUIA
QUINSTREET, INC AI-driven marketplaces connecting consumers to brands in finance & home services on a pay-per-result basis.	United States of America	QNST
Qurient Co., Ltd. Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.	South Korea	115180
Rafael Holdings, Inc. Invests in and develops novel therapeutics for cancer and rare diseases.	United States of America	RFL
RaQualia Pharma Inc. An R&D firm discovering novel small molecules for out-licensing to pharma partners.	Japan	4579
Recruit Holdings Co., Ltd. Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.	Japan	6098